Global DNA Probes-Based Diagnostics Market to Reach US$21.3 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on DNA Probe-Based Diagnostics markets. The global market for DNA Probe-Based Diagnostics is forecast to reach US$21.3 billion by the year 2015. Discovery of new diagnostic markers, increased automation of diagnostic tests, advancements in DNA array technologies, development of commercial diagnostic protocols through human genome data and higher profit margins are some of the key factors driving market growth.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
DNA Probes-Based Diagnostics: A Global Strategic Business Report

San Jose, CA (Vocus/PRWEB) January 18, 2011

The boom in the molecular diagnostics market is beginning to echo downstream into DNA-probe based diagnostics segment. The aging population is cited as a prime factor driving demand for healthcare medical diagnostics. Affluent population and widening health insurance, and medical reimbursements are additionally making expensive cutting edge diagnostic tools such as DNA based diagnostics increasingly affordable. In Asia, the aging population is expected to double by the year 2025, and the number of people requiring medical diagnosis and treatment is very likely to quadruple in the near future. The aging erudite population of the 21st century is additionally beginning to accept newer molecular based diagnostics such as NAT-based infectious diseases and viral assays, primarily because of their high levels of clinical efficacies.

DNA probes-based diagnostics are designed to study the chemical structure of DNA to unravel the presence of specific gene sequences and to analyze genetic information. The diagnostic tool seeks to identify abnormal gene sequences, which could be the potential cause for the disease, and therefore physicians can isolate the specific gene polymorphisms causing the disease. Demystifying the complexities of the genome is an ongoing high-profile research process, and DNA based probes represent the first step towards understanding a disease at the molecular level. The market for DNA-based technologies is expected to grow considerably in diagnostics as well as other application areas, including surface chemistry, instrumentation development, data handling, molecular biology, biological sample preparation, microfabrication, and molecular detection. Nevertheless, the widespread use of DNA based diagnostics is subject to the technology’s ability to overcome major challenges such as miniaturization, parallelization, and automation. In addition to these key challenges, improvements, and procedural refinement needs to be effected in the areas of sample preparation, assay technology, detection systems, integration, and data management and analysis. The culminated effect of all of these variables will help in determining the efficacy of the technology’s application in clinical diagnostics.

The US represents the largest regional market for DNA Probe-Based Diagnostics market worldwide, as stated by the new market research report on DNA Probes-Based Diagnostics. The US DNA-based diagnostic and test market is progressing towards a new phase. Transformational technologies in the market are enabling genomic and complex genetic tests to expand from research-only laboratories to clinical and medical laboratories. With rapid discoveries and developments in the genetic basis of a disease, this segment is set to progress at a fast pace. Europe trails behind the US, while the Latin American market is projected to register a compounded annual growth rate of 14.3% during the analysis period. Infectious Diseases represents the key end-use market for DNA Probes-based diagnostics worldwide. However, fastest growth is expected to emerge from Genetic Predisposition.

Major players profiled in the report include Abbott Laboratories, Affymetrix Inc, Becton Dickinson & Company, Beckman Coulter, Inc., bioMérieux, Gen-Probe Incorporated, Genzyme Corporation, QIAGEN, Roche Diagnostics and Siemens Healthcare Diagnostics, Inc.

The research report titled “DNA Probes-Based Diagnostics: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the DNA probe-based diagnostics markets, impact of the recession on the market, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for DNA Probe-Based Diagnostics market for the years 2007 through 2015 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific and Latin America. Also, a seven-year (2000-2006) historic analysis is provided for additional perspective.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/DNA_Probes_based_Diagnostics_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

# # #


Contact

Attachments